Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

NYSE:SGHC - New York Stock Exchange, Inc. - GG00BMG42V42 - Common Stock - Currency: USD

11.65  -0.12 (-1.02%)

After market: 11.65 0 (0%)

Fundamental Rating

6

Taking everything into account, SGHC scores 6 out of 10 in our fundamental rating. SGHC was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. SGHC has an average financial health and profitability rating. SGHC is growing strongly while it is still valued neutral. This is a good combination! These ratings could make SGHC a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.
Of the past 5 years SGHC 4 years were profitable.
Each year in the past 5 years SGHC had a positive operating cash flow.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

With an excellent Return On Assets value of 12.55%, SGHC belongs to the best of the industry, outperforming 88.64% of the companies in the same industry.
Looking at the Return On Equity, with a value of 21.14%, SGHC is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
SGHC has a Return On Invested Capital of 30.47%. This is amongst the best in the industry. SGHC outperforms 96.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SGHC is in line with the industry average of 13.91%.
The 3 year average ROIC (15.85%) for SGHC is below the current ROIC(30.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.55%
ROE 21.14%
ROIC 30.47%
ROA(3y)10.28%
ROA(5y)17.17%
ROE(3y)18.08%
ROE(5y)62.11%
ROIC(3y)15.85%
ROIC(5y)32.78%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

SGHC has a Profit Margin of 7.43%. This is in the better half of the industry: SGHC outperforms 62.12% of its industry peers.
In the last couple of years the Profit Margin of SGHC has declined.
SGHC has a better Operating Margin (14.99%) than 66.67% of its industry peers.
SGHC's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.99%
PM (TTM) 7.43%
GM N/A
OM growth 3Y-6.41%
OM growth 5YN/A
PM growth 3Y-26.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SGHC is creating value.
Compared to 1 year ago, SGHC has more shares outstanding
SGHC has more shares outstanding than it did 5 years ago.
SGHC has a worse debt/assets ratio than last year.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SGHC has an Altman-Z score of 10.12. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
SGHC has a better Altman-Z score (10.12) than 96.21% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SGHC is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.11, SGHC belongs to the best of the industry, outperforming 81.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 10.12
ROIC/WACC3.29
WACC9.27%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

SGHC has a Current Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a better Current ratio (1.42) than 71.21% of its industry peers.
SGHC has a Quick Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a better Quick ratio (1.42) than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

8

3. Growth

3.1 Past

SGHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 169.15%, which is quite impressive.
The earnings per share for SGHC have been decreasing by -16.35% on average. This is quite bad
SGHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.27%.
The Revenue has been growing by 28.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)169.15%
EPS 3Y-16.35%
EPS 5YN/A
EPS Q2Q%633.33%
Revenue 1Y (TTM)24.27%
Revenue growth 3Y8.72%
Revenue growth 5Y28.95%
Sales Q2Q%29.52%

3.2 Future

Based on estimates for the next years, SGHC will show a very strong growth in Earnings Per Share. The EPS will grow by 38.25% on average per year.
The Revenue is expected to grow by 13.18% on average over the next years. This is quite good.
EPS Next Y85.16%
EPS Next 2Y51.68%
EPS Next 3Y38.25%
EPS Next 5YN/A
Revenue Next Year22.34%
Revenue Next 2Y15.49%
Revenue Next 3Y13.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.89, SGHC can be considered very expensive at the moment.
SGHC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SGHC to the average of the S&P500 Index (27.50), we can say SGHC is valued inline with the index average.
A Price/Forward Earnings ratio of 14.81 indicates a correct valuation of SGHC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SGHC indicates a somewhat cheap valuation: SGHC is cheaper than 75.00% of the companies listed in the same industry.
SGHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.89
Fwd PE 14.81
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SGHC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.52
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

SGHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SGHC may justify a higher PE ratio.
SGHC's earnings are expected to grow with 38.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y51.68%
EPS Next 3Y38.25%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.36%, SGHC has a reasonable but not impressive dividend return.
SGHC's Dividend Yield is a higher than the industry average which is at 3.47.
With a Dividend Yield of 1.36, SGHC pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

SGHC is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y51.68%
EPS Next 3Y38.25%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

More info and screens

SUPER GROUP SGHC LTD

NYSE:SGHC (7/18/2025, 8:11:57 PM)

After market: 11.65 0 (0%)

11.65

-0.12 (-1.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners8.74%
Inst Owner Change0%
Ins Owners4.59%
Ins Owner ChangeN/A
Market Cap5.89B
Analysts85
Price Target14.43 (23.86%)
Short Float %2.71%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date06-23 2025-06-23 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.39%
Min EPS beat(2)-23.38%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.12%
Min EPS beat(4)-24.38%
Max EPS beat(4)20.66%
EPS beat(8)4
Avg EPS beat(8)52.32%
EPS beat(12)5
Avg EPS beat(12)27.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.51%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)8.12%
Revenue beat(4)2
Avg Revenue beat(4)2.66%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)8.12%
Revenue beat(8)6
Avg Revenue beat(8)4.69%
Revenue beat(12)9
Avg Revenue beat(12)4.1%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.9%
PT rev (3m)11.63%
EPS NQ rev (1m)18.52%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)5.78%
Revenue NQ rev (3m)9.76%
Revenue NY rev (1m)1.54%
Revenue NY rev (3m)7.72%
Valuation
Industry RankSector Rank
PE 25.89
Fwd PE 14.81
P/S 2.77
P/FCF N/A
P/OCF N/A
P/B 7.89
P/tB 14.13
EV/EBITDA 14.52
EPS(TTM)0.45
EY3.86%
EPS(NY)0.79
Fwd EY6.75%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.2
BVpS1.48
TBVpS0.82
PEG (NY)0.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.55%
ROE 21.14%
ROCE 38.57%
ROIC 30.47%
ROICexc 30.47%
ROICexgc 50.76%
OM 14.99%
PM (TTM) 7.43%
GM N/A
FCFM N/A
ROA(3y)10.28%
ROA(5y)17.17%
ROE(3y)18.08%
ROE(5y)62.11%
ROIC(3y)15.85%
ROIC(5y)32.78%
ROICexc(3y)21.16%
ROICexc(5y)N/A
ROICexgc(3y)71.43%
ROICexgc(5y)N/A
ROCE(3y)20.07%
ROCE(5y)41.49%
ROICexcg growth 3Y-50.54%
ROICexcg growth 5YN/A
ROICexc growth 3Y-26.74%
ROICexc growth 5YN/A
OM growth 3Y-6.41%
OM growth 5YN/A
PM growth 3Y-26.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 10.12
F-ScoreN/A
WACC9.27%
ROIC/WACC3.29
Cap/Depr(3y)74.8%
Cap/Depr(5y)56.21%
Cap/Sales(3y)4%
Cap/Sales(5y)3.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.15%
EPS 3Y-16.35%
EPS 5YN/A
EPS Q2Q%633.33%
EPS Next Y85.16%
EPS Next 2Y51.68%
EPS Next 3Y38.25%
EPS Next 5YN/A
Revenue 1Y (TTM)24.27%
Revenue growth 3Y8.72%
Revenue growth 5Y28.95%
Sales Q2Q%29.52%
Revenue Next Year22.34%
Revenue Next 2Y15.49%
Revenue Next 3Y13.18%
Revenue Next 5YN/A
EBIT growth 1Y205.38%
EBIT growth 3Y1.74%
EBIT growth 5YN/A
EBIT Next Year91.04%
EBIT Next 3Y32.21%
EBIT Next 5YN/A
FCF growth 1Y141.86%
FCF growth 3Y4.65%
FCF growth 5Y301.24%
OCF growth 1Y113.19%
OCF growth 3Y13.51%
OCF growth 5Y143.31%